ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hoth Therapeutics and WuXi strike API and drug product deal for cancer therapeutic
November 15, 2021WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide. -
Hoth Announces Positive Preclinical Results for Novel COVID-19 Therapeutic
March 29, 2021Hoth Therapeutics announced new in vitro data demonstrating SARS-CoV-2 antiviral activity for its lead peptide candidate for HT-002, a novel therapeutic targeted for the treatment of COVID-19. -
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.
March 14, 2019Hoth Therapeutics, Inc., a development-stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders...
Pharma Sources Insight January 2025
